Methods for detecting botulinum toxin with applicability to screening foods against biological terrorist attacks

Journal of Food Science

Volumn 70, Issue 8, 2005, Pages r121-r130

  Scarlatos, Amber ^a   Welt, Bruce A ^a   Cooper, Brian Y ^a   Archer, Douglas ^b   DeMarse, Thomas ^a   Chau, Khe V ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Botulism toxin; Clostridium botulinum; Detection; ELISA; Food safety; Immunoassay; Mass spectrometry; PCR

Indexed keywords

BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM BUTYRICUM;

EID: 27544478181     PISSN: 00221147     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2621.2005.tb11525.x     Document Type: Short Survey

References (58)

1. Ahnert-Hilger G, Bignalke H, 1995. Molecular aspects of tetanus and botulinum neurotoxin poisoning. Prog Neurobiol 46(1):83-96.
2. Akbulut D, Grant KA, McLauchin J. 2004. Development and application of real-time PCR assays to detect fragments of the Clostridium botulinum types A, B, and E neurotoxin genes for investigation of human foodborne and infant botulism. Foodborne Pathogens Dis 1(4):247-57.
3. Anne C, Cornille F, Lenoir C, Roques BP. 2001. High-throughput fluorogenic assay for determination of boutlinum type B neurotoxin protease activity. Anal Biochem 291:253-61.
4. Aranda E, Rodriguez MM, Asensio MA, Cordoba JJ. 1997. Detection of Clostridium botulinum types A, B, E and F in foods by PCR and DNA probe. Lett Appl Microbiol 25:186-90.
5. Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, OSterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. 2001. Botulism toxin as a biological weapon. JAMA 285(8):1059-70.
6. Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, McWilliams LG, Schmidt JG, Martinez RA, Ashley DL. 2005. Botulinum neurotoxin detection and differentiation by mass spectrocopy. Emerg Infect Dis 11(10):1578-83.
7. Branconnier A, Broussoule V, Perelle S, Fach P, Nguyen-The C, Carlin F. 2001. Screening for Clostridium botulinum type A, B and E in cooked chilled foods containing vegetables and raw material using polymerase chain reaction and molecular probes. J Food Protect 64(2):201-7.
8. Cadieux B, Blanchfield B, Smith JR Austin JW. 2005. A rapid chemiluminescent slot blot immunoassay for the detection and quantification of Clostridium botulinum neurotoxin type E, in cultures. Int J Food Microbio 101:9-16.
9. Campbell KD, Collins MD, East AK. 1993. Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. J Clin Microbiol 31(9):2255-62.
10. Caya JG, Agni R, Miller JE. 2004. Clostridium botulinum and the clinical laboratorian: a detailed review of botulism, including biological warfare ramifications of botulinum toxin. Arch Pathol Lab Med 128:653-62.
11. [CDC] Center for Disease Control and Prevention. 1998. Center for disease control and prevention: botulism in the United States, 1899-1996. Handbook for epidemiologists, clinicians and laboratory workers. Atlanta, Ga.: CDC.
12. Dahlenborg M, Borch E, Rådström R. 2001. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs. Appl Environ Microbiol 67(10):4781-8.
13. Dollegast GJ, Triscott MX, Beard GA, Bottoms JD, Cheng T, Roh BH, Roman MG, Hall PA, Brown JE. 1993. Sensitive enzyme linked immunosorbent assay for the detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme linked coagulation assay. J Clin Microbiol 31:2402-9.
14. Dollegast GJ, Beard GA, Bottoms JD, Cheng T, Roh BH, Roman MG, Hall PA, Triscott MX. 1994. Enzyme-linked immunosorbent assay for detection of Clostriduim botulinum neurotoxins A, B, and E and solution-phase complexes with dual labeled antibodies. J Clin Microbiol 32:105-11.
15. Ekong TAN, Feavers IM, Sesardic D. 1997. Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro. Microbiology 143: 3337-47.
16. Emanuel PA, Dang J, Gebhardt JS, Aldrich J, Garber EAE, Kulaga H, Stopa P, Valdes JJ, Dion-Schultz A. 2000. Recombinant antibodies: a new reagent for biological agent detection. Biosens Bioelectron 14:751-9.
17. Fach P, Gibert M, Griffais R, Guillou JP, Popoff MR. 1995. PCR and gene probe identification of botulinum neurotoxin A-, B-, E-, F- and G-producing Clostridium spp. and evaluation in food samples. Appl Environ Microbiol 61(1):389-92.
18. Fach P, Hauser D, Guillou JP, Popoff MR. 1993. Polymerase chain reaction for the rapid identification of Clostridium Botulinum type A strains in food samples. J Appl Bacteriol 75:234-9.
19. Ferreira JL, Baumstark BR, Hamdy MK, McCay SG. 1993. Polymerase chain reaction for detection of type A Clostridium botulinum in foods. J Food Protect 56(1):18-20.
20. Ferreira JL, Eliasberg SL, Edmonds P, Harrison MA. 2004. Comparison of the mouse bioassay and enzyme-linked immunosorbent assay procedures for the detection of type A botulinal toxin in food. J Food Protect 67(1):203-6.
21. Ferreira JL, Maslanka S, Johnson E, Goodnough M. 2003. Detection of botulinal neurotoxins A, B, E, and F by amplified enzyme-linked immunosorbent assay: collaborative study. JAOAC Int 86(2):314-31.
22. GenPrime. 2004. Home page. Available from: www.genprime.com. GenPRime. Spokane, Wash. Accessed 2004 July 19.
23. Hashsham SA, Wick LM, Rouillard JM, Gulari E, Teidje JM. 2004. Potential of DNA microarrays for developing parallel detection tools (PTDs) for microorganisms relevant to biodefense and related research. Biosens Bioelecron 20:668-83.
24. Hallis B, James BF, Shone CS. 1996. Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J Clin Microbiol 34:1934-8.
25. Keller JE, Nowakowski JL, Filbert MG, Alder M. 1999. Rapid microplate assay for monitoring botulinum neurotoxin B catalytic activity. J Appl Toxicol 19:S13-7.
26. Kimura B, Kawaski S, Nakano H, Fujii T. 2001. Rapid, quantitative PCR monitoring of growth of Clostridium botulinum type E in modified-atmosphere- packaged fish. Appl Environ Microbiol 67(1):206-16.
27. Lacy DB, Stevens RC. 1997. Recombinant expression and purification of the botulinum neurotoxin type A translocation domain. protein expression and purification 11:195-200.
28. Lindstrom M, Keto R, Annukka M, Nevas M, Hielm S, Korkeala H. 2001. Multiplex PCR assay for the detection and identification of Clostridium botulinum Types A, B, E, and F in food and fecal material. Appl Environ Microbiol 67(12):5694-9.
29. Li L, Sing BR. 1998. Isolation of synaptotagamin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a microtiter plate assay. J Nat Toxins 7:215-26.
30. Liu W, Montana V, Chapman ER, Mohideen U, Parpura V. 2003. Botulinum toxin type B micromeachanosesor. Proceedings of the National Academy of Sciences of the U.S.A. (PNAS) 100:13621-5.
31. Lövenklev M, Holst E, Borch E, Radstrom P. 2004. Relative neurotoxin gene expression in Clostridium botulinum type B, determined using quantitative reverse transcription PCR. Appl Environ Microbiol 70(5):2919-27.
32. Maksymowych AB, Reinhard M, Malizio CJ, Goodnough MC, Johnson EA, Simpson LL. 1999. Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade. Infect Immunol 67(9):4708-12.
33. Milkelsen SR, Cortón E. 2004. Bioanalytical chemistry. Hoboken, N.J.: John Whiley and Sons. 361 p.
34. McGrath S, Dooley JSG, Haylock RW. 2000. Quantification of Clostridium botulinum toxin gene expression by competitive reverse transcription-PCR. Appl Environ Microbiol 66(4):1423-8.
35. [NIAID] Natl. Inst. of Allergy and Infectious Disease. 2003 Summary of the NIAID expert panel on botulinum diagnostics. Bethesda, Md.: NIAID. Available from: www2.niaid.nih.gov/Biodefense. Accessed 2005 June 24.
36. New Horizon Diagnostics. 2005. Home page. Available from: http://www.nhdiag.com/index.htm. Columbia, Md.: New Horizons Diagnostics Cooperation. Accessed on 2005 July 17.
37. Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M, Kozaki S. 1994. Identification of a protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269:10498-503.
38. O'Brien T, Johnson LH, Aldrich JL, Allen SG, Liang LT, Plummer AL, Krak SJ, Boiarski AA. 2000. The development of immunoassays to four biological threat agents in a bidiffractive grating biosensor. Biosens Bioelectron 14:815-28.
39. Osborn Scientific Group. 2001. Osborne Scientific Group home page. Available from: http://osborn-scientific.com/. Accessed on 2005 July 17.
40. Peruski AH, Johnson LH, Peruski LF. 2002. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J Immunol Meth 263:35-41.
41. Rowe-Taitt CA, Golden JP, Feldstein MJ, Cras JJ, Hoffman KE, Liger FS. 2000. Array biosensor for detection of biohazards. Biosens Bioelectron 14:785-94.
42. Sciacchitano CJ, Hirshfield IN. 1996. Molecular detection of Clostridium botulinum type E neurotoxin gene in smoked fish by polymerase chain reaction and capillary electrophoresis. J AOAC Int 79(4):861-5.
43. Schmidt JJ, Stafford RG, Milliard CB. 2001. High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal Biochem 296:130-7.
44. Schmidt JJ, Stafford RG. 2003. Fluorogenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl Environ Microbiol 69:297-303.
45. Sharma KS, Eblen BS, Bull RL, Burr DH, Whiting RC. 2005. Evaluation of lateral flow Clostridium botulinum neurotoxin detection kits for food analysis. Appl Environ Microbiol 71:3935-41.
46. Shone C, Smith PW, Appelton N, Hambleton P, Modi N, Gatley S, Melling J. 1985. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comaparable to the mouse bioassay. Appl Environ Microbiol 50:63-7.
47. Simpson LL. 1996. Botulinum toxin: a deadly poison sheds its negative image. Ann Int Med 125:616-7.
48. Simpson LL. 2000. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie 82:943-53.
49. Simpson LL. 2004. Identification of the major steps in botulism toxin action. Ann Rev Pharmacol Toxicol 44:167-93.
50. Singh BR. 2000. Intimate details of the most poisonous poison. Nature Struct Biol 7:617-9.
51. Singh BR, Billian L, Read D. 1995. Botulism versus tetanus neurotoxins: why is a botulinum neurotoxin but not tetanus neurotoxin a food poison? Toxicon 33(12):1541-7.
52. Solomon HM, Lilly TL. 2001. FDA bacteriological analytical manual online. Chpt. 17. Clostridium botulinum. Available from: http//www.cfsan.fda.gov/~ebam- 17.html. Rockville, Md.: Center for Food Safety and Nutrition, U.S. Food and Drug Administration.
53. Trevan JW. 1927. The error of determining toxicity. Proc R Soc 101B:483-514.
54. [USFDA] U.S. Food and Drug Administration. 1992. The bad bug book, foodborne pathogenic microorganisms and natural toxins handbook: Salmonella spp. Available from: www.cfsan.fda.gov/~mow/chap1.html#education. Rockville, Md.: Center for Food Safety and Nutrition, U.S. Food and Drug Administration.
55. van Barr LM, Hulst AG, de Jong AL, Wils ERJ. 2002. Characterization of botulinum toxins A and B, by matrix-assisted laser desorption ionisation and electrospray mass spectrometry. J Chromatogr A 1035:95-115.
56. van Barr LM, Hulst AG, de Jong AL, Wils ERJ. 2004. Characterization of botulinum toxins C, D, E, and F by matrix-assisted laser desorption ionisation and eletrospray mass spectrometry. J Chromatogr A 970:97-114.
57. Wictome M, Newton K, Jameson K, Hallis B, Dunnigan P, Mackay E, Clark S, Taylor R, Gaze J, Foster K, Shone C. 1999. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay. Appl Environ Microbiol 65:3787-92.
58. Zilinskas RA. 1997. Iraq's biological weapons. The past as future? JAMA 278:418-24.